Ste. Genevieve Riverdogs Baseball Team Supports ALS Research
Prior to the final game of the season, the Ste. Genevieve Riverdogs baseball team surprised Coach Jeremy Hoog with a touching tribute as well as a donation to Dr. Timothy Miller’s ALS Research Lab in honor of Coach Hoog’s mother – and the Riverdogs’ biggest fan – Cheryl.
C9 ID: Accelerating a therapy for ALS patients with C9 mutations.
Dr. Timothy Miller provides an excellent explanation of how ALS works in the body and what researchers are doing to bring a therapy to ALS patients, especially those with mutation in the C9ORF72 gene.
Antisense ALS Trial: Antisense Therapy and the Creation of the SOD1 Protein.
Dr. Miller is featured in this MDA video about antisense oligonucleotides and their use in treating ALS.
ALS Ice Bucket Challenge helps fund Washington University’s research
Dr. Timothy Miller is featured in this news release describing how the money raised in the ALS Ice Bucket Challenge has helped discover new genetic causes of this disease.
NEALS Webinar: “C9: From ID (Identification) to Therapy”
Dr. Timothy Miller, Washington University, and Dr. Merit Cudkowicz, Massachusetts General Hospital, provide an update on the C9orf72 Natural History Study and discuss therapies in development for C9 patients. Steve Kolb, patient advocate, describes the motivation behind the project and explains how you can get involved.
2011 MDA Telethon ALS Research Update
MDA presents an update regarding research on ALS, featuring Dr. Timothy M. Miller from Washington University in St. Louis. MDA is supporting a clinical trial of antisense therapy seeking to counteract the affects of a toxic version of the protein SOD1 in patients with an inherited form of ALS.
2010 MDA Telethon ALS Research Update
MDA presents an update regarding research on ALS, featuring Dr. Timothy M. Miller from Washington University in St. Louis.